AllPortfolio news T3 Pharma raises over $12 million T3 Pharma, a spin-off of the University of Basel and one of our portfolio, has raised over $12 million from Boehringer Ingelheim Venture Fund and…Jérémie Meyer02.03.2020
Company interviewsInterviews “The first steps are slow and then suddenly things start rolling” After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup…Jérémie Meyer06.12.2019
Features Roivant raised USD 200 million, now valued at USD 7 billion The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an…Jérémie Meyer19.11.2018